Phung Phan

NPI: 1487152534
Total Payments
$2,961
2024 Payments
$674.52
Companies
15
Transactions
63
Medicare Patients
778
Medicare Billing
$177,621

Payment Breakdown by Category

Food & Beverage$2,914 (98.4%)
Education$46.91 (1.6%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,914 62 98.4%
Education $46.91 1 1.6%

Top Paying Companies

Company Total Records Latest Year
Otsuka America Pharmaceutical, Inc. $635.45 7 $0 (2024)
Alkermes, Inc. $423.32 8 $0 (2023)
Neurocrine Biosciences, Inc. $292.89 6 $0 (2022)
Janssen Pharmaceuticals, Inc $270.38 5 $0 (2024)
Teva Pharmaceuticals USA, Inc. $242.86 2 $0 (2024)
ITI, Inc. $216.38 5 $0 (2023)
ABBVIE INC. $208.07 6 $0 (2024)
Vanda Pharmaceuticals Inc. $125.00 1 $0 (2024)
E.R. Squibb & Sons, L.L.C. $121.03 1 $0 (2024)
Axsome Therapeutics, Inc. $120.42 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $674.52 7 Janssen Pharmaceuticals, Inc ($149.86)
2023 $1,082 9 Otsuka America Pharmaceutical, Inc. ($478.00)
2022 $805.30 26 Neurocrine Biosciences, Inc. ($237.11)
2021 $399.50 21 Alkermes, Inc. ($135.42)

All Payment Transactions

63 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/09/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $121.03 General
Category: Psychiatry/Psychology
12/04/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $15.12 General
Category: PSYCHIATRY
11/04/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.87 General
Category: NEUROSCIENCE
03/12/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $149.86 General
Category: Neuroscience
03/07/2024 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $121.84 General
Category: Neurology
02/26/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage Cash or cash equivalent $125.00 General
Category: SCHIZOPHRENIA
02/21/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII Food and Beverage In-kind items and services $118.80 General
Category: PSYCHIATRY
09/27/2023 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $120.06 General
Category: PSYCHIATRY
08/16/2023 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $122.03 General
Category: PSYCHIATRY
08/08/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $125.00 General
Category: NEUROSCIENCE
06/07/2023 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage Cash or cash equivalent $120.42 General
Category: Psychology/Psychiatric
05/30/2023 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $121.02 General
Category: Central Nervous System
05/02/2023 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $119.35 General
Category: PSYCHIATRY
04/12/2023 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $118.20 General
Category: PSYCHIATRY
03/29/2023 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $120.39 General
Category: PSYCHIATRY
03/15/2023 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Food and Beverage In-kind items and services $115.32 General
Category: CNS
08/16/2022 Indivior Inc. PERSERIS (Drug) Food and Beverage In-kind items and services $24.33 General
Category: BH
08/11/2022 Indivior Inc. PERSERIS (Drug) Food and Beverage In-kind items and services $24.76 General
Category: BH
06/30/2022 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $23.09 General
Category: Neuroscience
06/28/2022 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Food and Beverage In-kind items and services $99.91 General
Category: CNS
06/27/2022 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $16.03 General
Category: PSYCHIATRY
06/21/2022 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA INITIO Food and Beverage In-kind items and services $24.52 General
Category: CNS
06/03/2022 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $34.01 General
Category: Neuroscience
05/26/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.70 General
Category: NEUROSCIENCE
05/16/2022 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $39.51 General
Category: Neuropsychiatry

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 410 1,714 $258,225 $103,224
2022 5 248 1,067 $146,720 $56,401
2021 3 120 330 $44,925 $17,997
Total Patients
778
Total Services
3,111
Medicare Billing
$177,621
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 123 918 $137,700 $51,676 37.5%
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes Facility 2023 140 647 $80,875 $34,631 42.8%
99306 Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes Facility 2023 65 65 $19,500 $8,490 43.5%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 35 36 $10,800 $4,446 41.2%
90792 Psychiatric diagnostic evaluation with medical services Facility 2023 19 19 $4,275 $2,297 53.7%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 28 29 $5,075 $1,684 33.2%
99308 Follow-up nursing facility visit per day, typically 15 minutes Facility 2022 112 699 $87,370 $34,908 40.0%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 53 201 $30,150 $10,247 34.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 34 118 $14,750 $5,177 35.1%
99306 Initial nursing facility visit per day, typically 45 minutes Facility 2022 35 35 $10,500 $4,085 38.9%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 14 14 $3,950 $1,984 50.2%
99308 Subsequent nursing facility visit, typically 15 minutes per day Facility 2021 61 202 $25,250 $10,266 40.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 38 107 $13,375 $5,174 38.7%
99306 Initial nursing facility visit, typically 45 minutes per day Facility 2021 21 21 $6,300 $2,557 40.6%

About Phung Phan

Phung Phan is a Registered Nurse healthcare provider based in Anaheim, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2018. The National Provider Identifier (NPI) number assigned to this provider is 1487152534.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Phung Phan has received a total of $2,961 in payments from pharmaceutical and medical device companies, with $674.52 received in 2024. These payments were reported across 63 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,914).

As a Medicare-enrolled provider, Phan has provided services to 778 Medicare beneficiaries, totaling 3,111 services with total Medicare billing of $177,621. Data is available for 3 years (2021–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Registered Nurse
  • Other Specialties Adult|Psychiatric/Mental Health
  • Location Anaheim, CA
  • Active Since 01/24/2018
  • Last Updated 09/10/2021
  • Taxonomy Code 163W00000X
  • Entity Type Individual
  • NPI Number 1487152534

Products in Payments

  • REXULTI (Drug) $403.56
  • INGREZZA (Drug) $292.89
  • INVEGA SUSTENNA (Drug) $270.38
  • ABILIFY MAINTENA (Drug) $237.00
  • CAPLYTA (Drug) $216.38
  • LYBALVI (Drug) $215.23
  • ARISTADA (Drug) $208.09
  • VRAYLAR (Drug) $208.07
  • FANAPT (Drug) $125.00
  • UZEDY (Drug) $121.84
  • COBENFY (Drug) $121.03
  • Austedo XR (Drug) $121.02
  • Auvelity (Drug) $120.42
  • PERSERIS (Drug) $108.42
  • LATUDA (Drug) $104.60
  • TRINTELLIX (Drug) $40.80
  • ABILIFY MYCITE (Drug) $24.76
  • Wegovy (Drug) $21.62

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Registered Nurse Doctors in Anaheim